Sympathetic Neural Overdrive, Vascular Dysfunction and Diminished Exercise Capacity in Long COVID-19 Patients: A Long-Term Study of Cardiovascular Sequelae
Bruna E. Ono; João E. Izaias; Artur O. Sales; Thais S. Rodrigues; Camila S. Nunes; Jessica F. Niec; Natalia G. Rocha; Helena N.M. Rocha...
ACE-2-like Enzymatic Activity in COVID-19 Convalescent Patients with Persistent Pulmonary Symptoms Associated with Immunoglobulin
Yufeng Song; Frances Mehl; Lyndsey M. Muehling; Glenda Canderan; Kyle Enfield; Jie Sun; Michael Yin; Sarah J. Ratcliffe; Jeffrey M Wilson; Alexandra Kadl; Judith A...
PGE2 and HCN2 ion channels are critical mediators of pain initiated by angiotensin II
Pinto; Vilar; McNaughton
Angiotensin II is well known to have an important influence on blood pressure, mediated via the angiotensin II type 1 receptor (AT1R), and more recent studies have shown that...
Abnormalities of angiotensin regulation in postural tachycardia syndrome
Hossam I. Mustafa; Emily M. Garland; Italo Biaggioni; Bonnie K. Black; William D. Dupont; David Robertson; Satish R. Raj
BACKGROUND
Postural tachycardia syndrome (POTS) is a disorder characterized by excessive orthostatic...
Potential Mechanisms Underlying COVID-19-Mediated Central and Peripheral Demyelination: Roles of the RAAS and ADAM-17
Oliveira, Kellysson Bruno; de Souza, Fernanda Maria Araujo; de Sá, Letícia Barros Maurício; Pacheco, Amanda Larissa Dias; Prado, Mariana Reis; de Sousa Rodrigues, Célio Fernando...
Abstract
Background
Activation of the immune system is implicated in the Post-Acute Sequelae after SARS-CoV-2 infection (PASC) but the mechanisms remain unknown. Angiotensin-converting enzyme 2 (ACE2) cleaves angiotensin II (Ang II) resulting in decreased activation of the AT1 receptor and...
This is related to ME but I didn't see where else this might belong. So it's here:
https://www.ncbi.nlm.nih.gov/pubmed/29618472
I would like to have some thoughts on this research if anyone is able.
@Jonathan Edwards perhaps?
POTS is such a huge co-morbid issue for many of us.
Though I...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.